Large volume leukapheresis for collecting hemopoietic progenitors: role of CD 34+ precount in predicting successful collection

被引:15
作者
Menichella, G
Lai, M
Serafini, R
Pierelli, L
Vittori, M
Ciarli, M
Rumi, C
Puggioni, P
Scambia, G
Sica, S
Leone, G
机构
[1] Univ Cattolica Sacro Cuore, Chair Hematol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Obstet & Gynecol Inst, I-00168 Rome, Italy
关键词
peripheral blood stem cells; blood cell separators; CD34+cells;
D O I
10.1177/039139889902200508
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this work we evaluated the efficacy of stem cell collection with Large Volume Procedures. (LVP), and analysed the importance of the CD34+ cell precount in promoting the collection of a sufficient number of CD34+ cells for transplantation, using the Univariate Logistic Regression analysis. Eighty-nine leukapheresis were performed in 49 patients with hematological malignancies and solid tumors, mobilized with chemotherapy plus Granulocyte Colony Stimulating Factor (G-CSF). For each procedure 15.8 liters of blood were processed. The median value of Nucleated Cells (NC) and CD34+ cells precount was respectively 8.29 x 10(9)/ml (range 1.13 divided by 45.4) and 43.08 x 103/ml (range 1.06 divided by 795.2). Results show the capability of LVP to collect large quantities of hemopoietic progenitors with a median CD34+ cell total yield of 215.02 x 10(6) (range 5.03 divided by 2210). The yields per patients' body weight were: CD34+ cells 3.23 x 10(6)/kg (range 0.081 divided by 41.58). The regression analysis between blood cell precounts and collection yields gave the following correlations: the CD34+ cell precount correlates with CD34+ yield (r = 0.78 p < 0.00) and with CD34+ cell yield/kg (r = 0.76 p < 0.00). The number of CD34+ cells processed correlated with the number of CD34+ cells collected/kg (r = 0.83 p < 0.000). To investigate the importance of CD 341 cell precount in promoting CD34+ cell yields greater than or equal to 2.5 x 10(6)/kg we performed a Univariate Logistic Regression analysis that showed in our patients a probability of collecting greater than or equal to 2.5 x 106 CD34+/kg that rose from 0.6 to 0.95 for CD34+ precounts that oscillated from 30 to 40 x 10(3) CD34+ cells/ml, respectively. The Univariate Logistic Regression gave a probability of collecting greater than or equal to 2.5 x 10(6) CD34(+) cells/kg that oscillated between 0.64 divided by 0.98 for Values of CD34+ cells processed from 6 x 10(6)/kg to 8 x 10(6)/kg, p < 0.000. Sixty-three percent of patients reached the target dose of 2.5 x 10(6) CD34+ cells/kg with only one LVP. Until now 12 patients have been transplanted and all have had a prompt and complete lasting recovery. These results confirm the efficacy of LVP in harvesting hemopoietic progenitors and their ability in reconstituting hemopoiesis of transplanted patients, enabling the estimation of CD34+ precounts and CD34+ cells processed values, highly predictive for the collection of 12.5 x 10(6) CD34+ cells/kg. Furthermore, the Logistic Model suggests that the best strategy to plan a successful CD34+ cell collection procedure is to identify for each patient the amount of CD34+ cells/kg to be processed rather than the fixed processing of 3 divided by 5 blood volumes in all patients.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 26 条
[1]  
BENDER JG, 1994, BONE MARROW TRANSPL, V13, P479
[2]   PERIPHERAL-BLOOD STEM-CELLS (PBSCS) COLLECTED AFTER RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) - AN ANALYSIS OF FACTORS CORRELATING WITH THE TEMPO OF ENGRAFTMENT AFTER TRANSPLANTATION [J].
BENSINGER, WI ;
LONGIN, K ;
APPELBAUM, F ;
ROWLEY, S ;
WEAVER, C ;
LILLEBY, K ;
GOOLEY, T ;
LYNCH, M ;
HIGANO, T ;
KLARNET, J ;
CHAUNCEY, T ;
STORB, R ;
BUCKNER, CD .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :825-831
[3]   HEMATOPOIETIC STEM AND PROGENITOR CELLS FROM BLOOD - EMERGING USES FOR NEW COMPONENTS FOR TRANSFUSION [J].
COMENZO, RL ;
BERKMAN, EM .
TRANSFUSION, 1995, 35 (04) :335-345
[4]   AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - PRIOR EXPOSURE TO STEM CELL-TOXIC DRUGS DETERMINES YIELD AND ENGRAFTMENT OF PERIPHERAL-BLOOD PROGENITOR-CELL BUT NOT OF BONE-MARROW GRAFTS [J].
DREGER, P ;
KLOSS, M ;
PETERSEN, B ;
HAFERLACH, T ;
LOFFLER, H ;
LOEFFLER, M ;
SCHMITZ, N .
BLOOD, 1995, 86 (10) :3970-3978
[5]  
DZIECZKOWSKI JS, 1995, TRANSFUS SCI, V16, P71, DOI 10.1016/0955-3886(94)00061-N
[6]  
Efremidis AP, 1996, EUR J HAEMATOL, V57, P269
[7]   When to harvest peripheral-blood stem cells after mobilization therapy: Prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood [J].
Elliott, C ;
Samson, DM ;
Armitage, S ;
Lyttelton, MP ;
McGuigan, D ;
Hargreaves, R ;
Giles, C ;
Abrahamson, G ;
Abboudi, Z ;
Brennan, M ;
Kanfer, EJ .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :970-973
[8]   Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF [J].
Engelhardt, M ;
Winkler, J ;
Waller, C ;
Lange, W ;
Mertelsmann, R ;
Henschler, R .
BONE MARROW TRANSPLANTATION, 1997, 19 (06) :529-537
[9]  
HENON PR, 1992, BONE MARROW TRANSPL, V9, P285
[10]  
HOHAUS S, 1993, EXP HEMATOL, V21, P508